The use of modified carbohydrates, such as sugar amino acids (SAA), iminosugars and policyclic derivatives, as scaffolds for the generation of bioactive compounds, and the use of carbohydrates as building blocks or ligands for the production of polymers for biomedical applications, is reviewed.
No takes yet. Share an insight, caveat, or question.
Velter et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: